AB014. Effective somatostatin analogs in a case of advanced thymoma with no uptake in the octreotide scan

ABSTRACT:

Background

Management of advanced malignant thymoma is very challenging due to the lack of evidence from randomized trials. Despite advanced and non-curable status, most patients achieve long survival and they usually receive several treatment lines along their disease. There is no standard second line, and toxicity of chemotherapy (CT) should be considered for these long survivors. Treatment with somatostatin analogs showed efficacy in patients with refractory recurrent and/or metastatic thymomas.

Case Description

In January 2010, a 31-year-old woman was diagnosed of a mass in the anterior mediastinum with a biopsy compatible with thymoma B3 and myasthenia gravis. Thymoma was resected after 2 cycles of neoadjuvant CT with acronym: cisplatin, doxorrubicin, vincristine and

SUBMITTER:  

PROVIDER: S-EPMC9792819 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature